Home / News / SHL Medical / SHL Medical exhibits at SCbio 2024
Events| January 15, 2024

SHL Medical exhibits at SCbio 2024

SHL Medical will be at South Carolina, USA for SCbio 2024 on Feb 6-8.
Learn about SHL Medical’s global expansion, comprehensive solutions, and more at SCbio 2024

SHL Medical is set to exhibit at the annual life science conference, SCbio 2024 – The Science of Success, on Feb 6-8 at Greenville, South Carolina, USA.

SHL Medical’s new manufacturing site in North Charleston, South Carolina, USA is set for a grand opening this 2024. This strategic growth initiative is part of our commitment to bringing innovative solutions closer to our pharma partners and patients in the Americas. Participating in SCbio 2024 is a pivotal step to expand our network, allowing us to connect with experts from medtech, biomaterial, and diagnostic industries, as well as exchange insights on the latest advancements across the life sciences spectrum.

Beyond our global expansion, participants of SCbio 2024 can explore SHL Medical’s comprehensive in-house manufacturing capabilities and vertically integrated business model. Last year, we introduced the Alliance Management Program – an initiative that seeks to foster deeper engagement between our customers and key players in the drug delivery industry. Join our experts at SCbio 2024 and discover how SHL Medical can support the evolving needs of both the life science and drug delivery industries.

 
Book a meeting

 

Where  : Hyatt Regency Greenville, South Carolina, USA

When   : Feb 6-8

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News